Cognitive impairment in ICU survivors: assessment and therapy

Cleve Clin J Med. 2012 Oct;79(10):705-12. doi: 10.3949/ccjm.79a.12038.

Abstract

Cognitive impairment occurs in up to one-third of intensive care patients and may affect one or more cognitive domains. Because data are scarce on therapies for this complication, prevention remains the prevailing strategy. In this review, we discuss the clinical approach to cognitive impairment after an intensive care unit (ICU) stay.

Publication types

  • Review

MeSH terms

  • Cholinesterase Inhibitors / therapeutic use
  • Cognition Disorders / diagnosis
  • Cognition Disorders / drug therapy*
  • Cognition Disorders / psychology
  • Cognition*
  • Cognitive Behavioral Therapy
  • Critical Illness*
  • Donepezil
  • Dopamine Uptake Inhibitors / therapeutic use
  • Humans
  • Indans / therapeutic use
  • Intensive Care Units*
  • Methylphenidate / therapeutic use
  • Piperidines / therapeutic use
  • Psychometrics
  • Survivors*

Substances

  • Cholinesterase Inhibitors
  • Dopamine Uptake Inhibitors
  • Indans
  • Piperidines
  • Methylphenidate
  • Donepezil